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1. Introduction 
Over the last decades, renal transplantation has evolved from an experimental procedure 
into the treatment of choice for children with end-stage renal disease. Differences in size and 
weight of the recipient, cause of renal failure, immune responsiveness, susceptibility to 
infection, pharmacokinetics of immunosuppressive drugs, and psychological aspects 
distinguish renal transplantation in children from adults. The longevity of an allograft is 
particularly important for the pediatric transplant recipient, because renal replacement 
therapy is necessarily a lifelong undertaking. The aim of the present study is to determine 
by means of a multivariable analysis the factors that significantly affect graft outcome in the 
paediatric transplant population. Knowledge of predictors of graft survival can be beneficial 
in planning the renal replacement therapy in children and improving transplantation 
results.  
Registry studies, essentially from the North American Pediatric Renal Trials and 
Collaborative Studies (NAPRTCS) (Benfield et al., 1999; NAPRTCS, 2010) and from the 
United Network for Organ Sharing (UNOS) (Hwang et al., 2005), have been performed to 
analyse factors related to graft outcome in children. Registry studies have the advantage of 
being able to include large number of patients. However these studies usually involve 
heterogeneous populations with different pre-transplant selections, transplant procedures 
and post-transplant management. Therefore single center studies using a more 
homogeneous patient group and more uniform management protocols may be valuable in 
the analysis of transplant outcome. Nevertheless such single center studies using 
multivariable techniques to analyse transplant outcome are very scarce in paediatric renal 
transplantation (Vats et al., 2002).  
We analysed all renal transplantations performed in children at our institution between 1980 
and 2010 and included in our analysis various factors concerning recipient characteristics, 
donor characteristics, perioperative characteristics and post-transplant events.  
2. Patients, materials and methods 
2.1 Patients 
The study population consisted of 151 kidney transplants performed between June 1980 and 
October 2010 in 135 children (81 boys and 54 girls) with mean age 10.7 years (± 4.9) at 
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transplantation. There were 132 first grafts, 15 second grafts, 3 third grafts and 1 fourth 
graft. 
The original disease was congenital or hereditary in 74% and acquired in 26%. Thirteen 
children were transplanted preemptively. Kidney came from living related donors (LRD) in 
33 cases (22%) and from deceased donors (DD) in 118 cases (78%). Four children underwent 
combined liver-kidney transplantation. 
Immunosuppression consisted of an induction with antilymphocyte antibodies and a 
maintenance regimen with cyclosporine A (CsA) (since December 1984), azathioprine and 
prednisolone. Newer immunosuppressive agents were introduced more recently: tacrolimus 
in 1998, mycophenolate mofetyl in 1998, basiliximab and daclizumab in 1999. 
2.2 Data source 
Data were retrieved from the patients’ medical files and from the archives and database of 
Eurotransplant. The follow-up period ended in February 2011. 
2.3 Analytic variables and statistical analysis  
The following variables were studied as potential factors affecting graft outcome: 
- Recipient characteristics: age (years), gender, height (cm), weight (kg), body surface area 
(BSA, m2), body mass index (BMI, kg/m2), prior transplant, primary kidney disease, 
peak and current panel-reactive antibody percentage (PRA), ABO blood group, CMV 
serological status, number of prior blood transfusions (0-5 vs. >5), native nephrectomy, 
dialysis modality before transplantation, dialysis duration (years), time on the waiting 
list (years), hypertension (defined as the use of antihypertensive medications), year of 
transplantation.  
- Donor characteristics: age, gender, height, weight, BSA, BMI, ABO group, CMV status, 
donor type (LRD vs. DD), cause of death for the deceased donors, serum creatinine 
level (mg/dl) at organ retrieval, diuresis (ml) during the last 24 hours and the last hour 
before organ retrieval. 
- Donor recipient relationships: donor/recipient age ratio, height ratio, weight ratio, BSA 
ratio, BMI ratio, gender mismatch, human leukocyte antigen (HLA) mismatch, ABO 
mismatch (all grafts were ABO compatible but one), CMV mismatch (D+/R-, D-/R+, 
D+/R+, D-/R-). 
- Organ preservation and perioperative characteristics: donor kidney preservation solution 
(Eurocollins (EC) vs. University of Wisconsin (UW) vs. histidine–tryptophan-
ketoglutarate (HTK)), cold ischemia time (hours), warm ischemia time (minutes).  
- Immunosuppression: induction therapy (polyclonal vs. monoclonal vs. none) and 
maintenance immunosuppression at time of discharge from the initial hospitalization 
including use of calcineurin inhibitors and type (CsA vs. tacrolimus), use of 
antimetabolites and type (azathioprine vs. mycophenolate mofetyl). 
- Post-transplant characteristics: duration of initial transplant hospitalization (days), 
occurrence of delayed graft function (DGF) defined as the need for dialysis in the first 
week post-transplant, occurrence of acute rejection episodes, creatinine clearance 
(ml/min/1.73 m2) at 1 year post-transplant (calculated using the Schwartz formula: 
creatinine clearance = 0.55*height (cm)/plasma creatinine (mg/dl)), hypertension 
(defined as the use of antihypertensive medications) and its severity as reflected by the 
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number of antihypertensive medications at 1 year post-transplant, proteinuria  
(>1 g/24 h) at 1 year post-transplant, hemoglobin (g/dl) at 1 year post-transplant.  
Acute Rejection was defined as any rejection treatment. Acute rejection was suspected when 
the serum creatinine level increased to 20% above the baseline level and was biopsy proven 
in most cases. 
Univariable analysis was performed on each of these variables using the Cox proportional 
hazards regression model. Variables with a p-value <0.10 in the univariable analysis were 
then entered into the multivariable analysis. Cox regression was applied with forward 
stepwise selection using likelihood-ratio tests. Variables were retained in the model at 
p<0.05. Acute rejection was considered as a time dependent covariate. 
The hazard ratios (HR) for graft failure and corresponding 95% confidence intervals were 
estimated. Graft failure was defined as return to dialysis, re-transplantation or death with a 
functioning graft. Graft survival time was defined as the time between the date of 
transplantation and graft failure or the end of the study period. 
Two models were constructed: one starting at the time of transplantation thus including all 
transplants (n=151) and one starting after the end of the first year post-transplant including 
transplants that functioned beyond the first year (n=140). Hypertension at 1 year, creatinine 
clearance at 1 year, proteinuria at 1 year (>1 g/24 h), hemoglobin at 1 year were included in 
the second model as additional potential predictors for graft survival after 1 year. 
Patient and graft survivals were calculated with the Kaplan–Meier method. 
Statistical analyses were performed using Statistica 8.1 (StatSoft Inc., Tulsa, OK., USA)  
and SPSS 18.0 (SPSS Inc., Chicago, IL., USA). Statistical significance was defined as  
p<0.05. 
3. Results 
3.1 Patient and graft survival 
The actuarial patient survival was 97% at 1 year, 96% at 3 years, 94% at 5 years and 92% at 
10 years (Figure 1). Nine patients died, three of them with a functioning graft. The cause of 
death was bacterial infection in four children, Pneumocystis carinii infection in one, 
malignant lymphoproliferative disorder in one, and a cardiovascular complication in three 
(two of whom died following cerebral haemorrhage and one following a myocardial 
infarction). 
The overall actuarial graft survival was 94% at 1 year, 86% at 3 years, 80% at 5 years and 
64% at 10 years (Figure 1). Mean follow-up time was 9.3 ± 6.5 years. 
The actuarial graft survival at 1, 3, 5, 10 years was 94%, 90%, 83% and 68% respectively for 
recipients of living-related donor and 94%, 83%, 79% and 63% respectively for recipients of 
deceased donor (Log-Rank Test p=0.95). In children younger than 5 years the graft survival 
was 92% at 1 and 3 years, and 83% at 5 and 10 years; in this group the prevalence of LRD 
was rather high (11/24; 46%).  
In total 68 grafts were lost during the study period, 9 of them during the first year post-
transplant. The causes of graft loss are given in Table 1; chronic rejection being the leading 
cause. Non compliance was documented in 19% of the failure due to chronic rejection (9 
cases). Recurrence of the initial disease was the second most frequent cause of graft failure. 
The main characteristics of the study population are detailed in Table 2. 
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Fig. 1. Kaplan Meier plot of patient and graft survivals (n indicates the number of subjects at 
risk at 0, 3, 5 and 10 years).  
 
 
 n                    % 
Chronic rejection 47 69.1 
Recurrence of primary disease 8 11.8 
Death with functioning graft 3 4.4 
Malignancy 2 2.9 
Infection  2 2.9 
Technical failure 2 2.9 
Primary non-function  2 2.9 
Polyoma nephropathy 1 1.5 
Thrombosis renal artery 1 1.5 
 
Table 1. Causes of graft failure   
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 N* Mean ± SD  or n Range or % 
Recipient characteristics    
Age (year)  10.7 ± 4.7 1.3-21.9 
  0-4   24 15.9% 
 5-9  38 25.2% 
 10  56 59.0% 
Gender M/F  91/60 59.6/40.4% 
Weight (kg)  20.5 ± 14.5 8.4-76.4 
Primary Tx/ReTx  132/19 87.4/12.6% 
Primary kiney disease    
  Congenital uro-nephropathy  72 47.7% 
  Hereditary nephropathy  40 26.5% 
  Acquired nephropathy  39 25.8% 
Renal replacement therapy at Tx    
  Hemodialysis  125 76.1% 
  Peritoneal dialysis  22 14.6% 
  Transplantation  1  0.7% 
  None   13  8.6% 
Years of pre-transplant dialysis  1.93 ± 1.73 0-8.18 
Years on waiting list 106 1.26 ± 1.12 0.04-6.25 
>5 pre-transplant transfusions  62 41.1% 
Current PRA>50%/Peak PRA>50%  16/33 10.6/21.9% 
CMV serology: neg/pos/unknown  114/36/1 75.5/23.8/0.7% 
On Antihypertensiva at time of Tx  149 81 54.4% 
Donor characteristics    
Age (year)  23.8 ± 14.8 0.5-54.5 
  0-4   18 11.9% 
  5-19  48 31.8% 
  20-39  54 35.8% 
  40-55  31 20.5% 
Gender M/F  150 86/64  57.3/43.7% 
Weight (kg) 127 55.5 ± 23.5 7-101 
Donor type    
  DD/LRD  118/33 78.1/21.9% 
Cause of donor death  117   
  Trauma/CVA/others  71/24/22 60.7/20.5/18.8% 
Donor /Recipient relationships    
Donor/Recipient Weight ratio 127 2.35 ± 1.78 0.29-8.47 
Donor/Recipient BSA ratio 125 1.70 ± 0.88 0.21-4.51 
Donor/Recipient BMI ratio 125 1.28 ± 0.28 0.53-2.15 
CMV serology 134   
  D-/R-  68  
  D-/R+  23  
  D+/R-  33  
  D+/R+  10  
Table 2. Characteristics of the study population  
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 N* Mean ± SD  or n Range or % 
HLA Mismatch 150   
  HLA-A   0.83 ± 0.60  
      0/1/2  42/91/17 28.0/60.7/11.3% 
  HLA-B  1.03 ± 0.51  
      0/1/2  17/111/22 11.3/74.0/14.7% 
  HLA-DR  0.77 ± 0.55  
      0/1/2  44/97/9 29.3/64.7/6.0% 
  HLA-ABDR  2.62 ± 1.06  
      0  7 4.7% 
      1  9 6.0% 
      2  46 30.7% 
      3  67 44.7% 
      4  15 10.0% 
      5  5 3.3% 
      6  1 0.7% 
Perioperative characteristics    
Organ preservation solution 149   
  Eurocollins/UW/HTK  48/64/37 32.2/43.0/24.8% 
Cold ischemia time (hours) for DD  117 20.34 ± 7.70 8.40-50.47 
      >30 hr  10 9.3% 
Warm  ischemia time (min) 148 38.1 ±.11.8 15.0-95.0 
       >40 min   53 35.8% 
Immunosuppression (IS)    
Induction  150   
  Polyclonal (ALS/ATG) 92 (43/49) 61.3% 
  Monoclonal (anti-IL2r/OKT3) 52 (51/1) 34.7% 
  None 6  4%
Maintenance IS at discharge
  Cyclosporine A/Tacrolimus/No 104/31/16 68.9/20.5/10.6% 
  Azathioprine/MMF/No 104/45/2 68.9/29.8/1.3% 
Post-transplant characteristics
Tx hospitalization (days) 19.3 ± 12.9 7-113 
Delayed graft function(DGF) 25 16.6% 
Acute rejection 
  Yes vs. No  69/82 45.7/54.3 % 
  Within the first year post Tx 58 38.4 % 
  Beyond the first year post Tx 23 15.7 % 
  Time first rejection episode (days) 46 (10-174)§ 1-5474 
Hemoglobin level at 1 yr (g/dl) 139 11.5 ± 1.4 6.4-14.0 
Proteinuria (>1 g/24 h) at 1 yr 140 10 7.1% 
Creatinine Clearance at 1 yr 
(ml/min/1.73 m2)
140 72.1 ± 22.0 14.7-156.5 
*N=number of transplants for whom data are available; if not specified n=151. §data given as median 
(interquartile range). CVA: cardiovascular accident; DD: deceased donor; DGF: delayed graft function ; 
LRD: Living related donor. 
Table 2. Cont.  
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3.2 Univariable analysis of factors influencing graft outcome 
Table 3 summarizes the predictors of graft outcome in univariable analysis (p<0.10).  
Duration of pre-transplant dialysis, multiple blood transfusions pre-transplant (>5), warm 
ischemia time (superior to 40 min), cold ischemia time, delayed graft function (DGF) and 
acute rejection were found to significantly affect outcome adversely. Transplants that did 
not benefit from calcineurin inhibitors had a fourfold increased risk of graft failure 
(p<0.0001). In addition, over the time of our transplant program, there was a significant 
lower risk for graft failure with each subsequent year (p=0.008). As far as HLA matching is 
concerned, two mismatches on HLA-A tended to be detrimental (p=0.064). 
Kidney function (creatinine clearance) at 1 year, proteinuria (>1 g/24 h) at 1 year and the 
level of hemoglobin at 1 year were found to be significant predictors of graft outcome for the 
transplants that functioned beyond the first year. Risk of graft loss increased with the 
presence of proteinuria and decreased with an increase in hemoglobin level and an increase 
in creatinine clearance.  
Variables that were not retained as predictors (p>0.10) of graft outcome included among 
others: primary kidney disease, recipient and donor gender and age, recipient and donor 
anthropometric parameters (weight, height, BSA, BMI), age ratio and anthropometric 
parameters ratio between the donor and the recipient, peak and current PRA levels, 
recipient and donor blood group, donor type, organ preservation solution type, CMV 
matching status, repeat transplant, and hypertension at transplantation and at 1 year post-
transplant. 
 
 df HR 95% CI p Value 
Time on dialysis (years)  1 1.17 1.02-1.34 0.030 
>5 Transfusions pre-Tx 1 1.82 1.12-2.97 0.016 
HLA-A mismatch (2 vs. 0-1) 1 1.96 0.96-3.98 0.064 
Cold ischemia time (h) (DD)     
continue variable 1 1.03 1.002-1.065 0.034 
>30 h vs. ≤ 30 h 1 2.63 1.31-5.26 0.006 
Warm ischemia time (min)      
as continue variable 1 1.016 0.996-1.037 0.11 
>40 min vs. ≤ 40 min 1 1.66 1.02-2.71 0.042 
Year of transplantation 1 0.95 0.91-0.99 0.008 
Absence of calcineurin inhibitors 1 4.31 2.44-7.63 <0.0001 
Dialysis in the first week post-Tx (DGF) 2   0.001 
  Risk graft failure within first 3 months 1 16.89 3.41-83.80 0.001 
  Risk graft failure after first 3 months 1 1.05 0.54-2.04 0.88 
Acute rejection  1 2.61 1.55-4.40 0.0003 
Proteinuria (>1 g/24 h) at 1 year  1 4.13 2.01-8.48 0.0001 
Hemoglobin at 1 year (g/dl) 1 0.67 0.54-0.82 0.0002 
Creatinine clearance at 1 year 
(ml/min/1.73 m2) 
1 0.97 0.95-0.98 <0.0001 
df: degrees of freedom; HR: hazard ratio; CI: confidence interval  
Table 3. Predictors of graft outcome in univariable analysis (p<0.10) 
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3.3 Multivariable analysis of factors influencing graft outcome 
3.3.1 Considering all transplants - graft survival from the time of transplantation 
Multivariable Cox regression analysis showed that the significant factors contributing to 
graft failure were: absence of calcineurin inhibitors, two mismatches on HLA-A, occurrence 
of acute rejection and occurrence of DGF. The need for dialysis in the first week post-
transplant was linked with a very high risk for graft failure within the first three months 
post-transplant; beyond this period it had no significant impact on graft outcome.  
The hazard ratios for graft failure and their confidence intervals are given in Table 4.  
The other factors that were found significant in univariable analysis (multiple pre-transplant 
transfusions, cold and warm ischemia times, year of transplantation, duration of 
pre-transplant dialysis) did not significantly affect outcome when subjected to a 
multivariable analysis.  
 
 df HR 95% CI p Value 
Absence of calcineurin inhibitors 1 3.98 2.15-7.36 <0.0001 
2 HLA-A mismatches 1 2.77 1.31-5.84 0.008 
DGF 2   0.002 
  Risk graft failure within first 3 months 1 3.21 2.62-66.50 0.002 
  Risk graft failure after first 3 months  1 1.31 0.66- 2.61 0.44 
Acute rejection  1 2.10 1.25-3.52 0.005 
Likelihood ratio Chi-square 46.208, df 5, p<0.0001 (n=150) 
Table 4. Multivariable Cox regression analysis of graft survival from the time of 
transplantation: analysis of all grafts. 
3.3.2 Considering transplants with ≥ 1 year survival - graft survival after 1 year  
This analysis was done on the subset of transplants that were still functioning at 1 year. 
Nine grafts were lost in the first year. Multivariable Cox regression analysis showed that 
significant risk factors contributing to graft failure after 1 year were: absence of calcineurin 
inhibitors, two HLA-A mismatches, kidney function (creatinine clearance) at 1 year, 
proteinuria at 1 year (superior to 1 g/24 h) and hemoglobin level at 1 year. 
The hazard ratios for graft failure and their confidence intervals are given in Table 5. 
 
 df HR 95% CI p Value 
Absence of calcineurin inhibitors 1 6.73 3.19-14.21 <0.0001 
2 HLA-A mismatches 1 3.25 1.45-7.27 0.004 
Creatinine clearance at 1 yr (ml/min/1.73 m2) 1 0.97 0.96-0.99 0.002 
Proteinuria (>1 g/24 h) at 1 yr 1 3.13 1.44-6.81 0.004 
Hemoglobin level at 1 yr (g/dl) 1 0.76 0.61-0.94 0.011 
Likelihood ratio Chi-square 52.383, df 5, p<0.0001 (n=139) 
Table 5. Multivariable Cox regression analysis of graft survival after 1 year post-
transplantation: analysis of grafts that survived beyond the first year. 
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4. Discussion 
This single center study investigated factors that affect renal transplant outcome in children. 
Numerous factors concerning recipient characteristics, donor characteristics, perioperative 
characteristics and post-transplant events were included in the analysis. 
Univariable analysis identified a number of factors associated with outcome. Multiple blood 
transfusions pre-transplant, duration of dialysis pre-transplant, prolonged cold and warm 
ischemia times, absence of calcineurin inhibitors, occurrence of acute rejection, occurrence of 
delayed graft function, absence of HLA-A matching, presence of marked proteinuria at 1 
year post-transplant were associated with poor outcome. Risk of graft failure decreased with 
higher creatinine clearance at 1 year, higher level of hemoglobin at 1 year and later year of 
entry in the transplant program. Certainly in term of single variable determinants, these 
specific factors appear familiar to professionals in renal transplantation. 
The following factors remained of significance after multivariable analysis: use of 
calcineurin inhibitors, absence of HLA-A matching, delayed graft function defined as the 
need for dialysis in the first week post-transplant, occurrence of acute rejection, proteinuria 
superior to 1 g/24 h at 1 year, hemoglobin level at 1 year and kidney function at 1 year. 
Transplants that did not benefit from calcineurin inhibitors had a fourfold increased risk of 
graft failure. Most of these transplants (14 of 16) were performed in the period 1980-1984 
before CsA was introduced. As the period 1980-1984 represents also the first years of our 
pediatric transplant program, the lack of center experience, the so called learning curve, may 
be partly a confounding factor. We found CsA to impact significantly and independently 
both on early and long term graft survival. This is similar to the findings of two single center 
pediatric studies (Chavers et al., 1994; Offner et al., 1999) reporting a beneficial effect of CsA 
up to 5 and 8 years post-transplant. The introduction of CsA in the mid-1980s for the 
prevention of acute rejection has been a major breakthrough in the transplantation field. 
However it has been reported to impact mostly on early graft survival by lowering acute 
rejection rates; its effect on long term outcome being much more controversial (Chapman & 
Nankivell, 2006; Pascual et al., 2002; Schurman & McEnery, 1997). One of the major concerns 
for long term outcome is the calcineurin inhibitor-induced chronic nephrotoxicity leading to 
progressive nephron loss and declining renal transplant function (Chapman & Nankivell, 
2006; Nankivell et al., 2004). Hence with the broadening of the immunosuppressive drugs 
arsenal, calcineurin inhibitor minimization, calcineurin inhibitor withdrawal or avoidance 
strategies have been developed. Calcineurin inhibitor withdrawal and avoidance protocols 
have been associated with an amelioration of the renal function, however at the cost of a 
higher rejection rates (Guerra et al., 2007; Höcker & Tönshoff, 2011). The long-term safety 
and efficacy of calcineurin inhibitor withdrawal and avoidance strategies need to be further 
validated in controlled clinical trials. At present the safest therapeutic strategy for pediatric 
renal allograft with chronic calcineurin inhibitor induced nephrotoxicity appears to be a 
mycophenolate based regimen with low dose calcineurin inhibitor and corticosteroids 
(Höcker & Tönshoff, 2011). 
Two HLA-A mismatches was in our population a strong predictive risk factor for graft 
failure. Matching for HLA-DR and HLA-B has generally received priority over matching for 
HLA-A in children as well as in adults. Multivariable analysis of the data from the large 
NAPRTCS registry showed that the absence of HLA-B match and the absence of HLA-DR 
match were significant risk factors for graft failure (NAPRTCS, 2010). Roberts and 
colleagues reported that matching at the HLA-DR locus has significant effect on the survival 
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of renal grafts from DD whereas matching at the HLA-A and B loci has only small effect 
(Roberts et al., 2004). However, Zantvoort and colleagues from Eurotransplant (Zantvoort et 
al., 1996) found an independent HLA-A matching effect on long term survival of DD kidney 
grafts with an increasing effect over time (up to 6 years post-transplant). This was in 
contrast to the strong, short-lived, effects of HLA-DR and -B matching, which could only be 
detected up to 6 months and 2 years after transplantation, respectively. A clear additive 
beneficial effect of HLA-A matching was shown in the group without B and DR mismatches. 
They concluded that prospective matching for the HLA-A antigens remains important for 
renal allograft survival and our data are in agreement with this. Data from the Collaborative 
Transplant Study indicated that class II HLA-DR locus has a stronger impact than the class I 
HLA-A and HLA-B loci during the first post-transplant year but that during subsequent 
years the three loci have an equivalent and additive influence on graft survival: to obtain 
optimal long term survival all three loci must be considered in the donor-recipient matching 
procedure (Opelz et al., 1999). This has been our policy through the years of our program as 
reflected by the very low percentage of transplants with more than 3 HLA-A,-B,-DR 
mismatches (14%). Obtaining the best possible HLA match for children is also an important 
part of the Eurotransplant allocation process. In contrast, in the United States, matching for 
HLA-A and –B has been abandoned and only HLA-DR is considered during the kidney 
allocation process. Based on an retrospective analysis of the UNOS registry data from 1585 
pediatric recipients of DD kidney between 1996-2004 showing no advantage for HLA-DR 
matching, it has been recommended that, in the modern era of immunosuppression, the 
HLA match should be entirely disregarded when allocating donor kidneys to pediatric 
recipients (Gritsch et al., 2008). This will allow shortening the waiting time on dialysis for 
children. This view has been challenged in a recent report by Opelz and Döhler who 
examined the outcomes of 9209 pediatric recipients of DD kidneys from the CTS registry 
(Opelz & Döhler, 2010). Comparing two decades (1988-1997 and 1998-2007), they showed 
that, although overall graft survival improved over time, HLA matching remained highly 
significant and similarly strong despite the introduction of newer and more potent 
immunosuppression. A hierarchical relationship was observed for the effect of increasing 
number of mismatches on graft survival in both periods. Interestingly, they found a strong 
association between two HLA-DR mismatches and non Hodgkin lymphoma, and 
recommended therefore to avoid transplants with 2 HLA-DR mismatches.  
In our view, a well matched first kidney is especially important in children as they have a 
high likelihood of needing more than one transplant during their lifetime. A poor matched 
kidney is more likely to result in HLA allosensitization, resulting therefore in long waiting 
time for a second transplant when the first graft fails and compromising the chance of a 
successful retransplantation (Meier-Kriesche et al., 2009). 
The need for dialysis in the first week after transplantation carried in our transplant 
population a very high risk of graft failure within the first months post-transplant but did 
not impact significantly on the long term outcome. Similar findings emerged out of the 
analysis of the NAPRTCS registry (Tejani et al., 1999). DGF was found to be a significant 
independent predictor of graft failure. However, when patients whose grafts had failed 
during the first year were censored, no differences in graft survival were noted between 
patients with and without DGF for either LRD or DD recipients. Similarly DGF was not an 
independent predictor of long term graft survival in a large single center analysis of 
pediatric renal recipients (Vats et al., 2002). Good long term graft survival has also been 
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obtained with non-heart-beating donors despite a higher incidence of DGF (Koffman & 
Gambaro, 2003; Sanchez-Fructuoso et al., 2004; Summers et al., 2010). Others have reported a 
negative influence of DGF on long term graft outcome (Gjertson, 2000; Moreira et al., 2011). 
It remains however difficult to determine whether this negative impact of DGF is 
independent of two associated known risk factors for long-term outcome: acute rejection 
(AR) and degree of kidney function (Geddes et al., 2002; Troppmann et al., 1996). The 
combination of DGF and AR seems to be the most detrimental for graft survival (Matas et 
al., 2000; McLaren et al., 1999).  
The occurrence of acute rejection was an independent predictor of graft survival when all 
transplants were included in the analysis. When only the grafts that functioned beyond the 
first year were considered, acute rejection disappeared from the significant factors in the 
multivariable analysis. The lack of significance can be due to the reduced power as acute 
rejection was introduced as a time dependent covariate and most of the events (acute 
rejection) occurred within the first year. 
Acute rejection is an important predictor of chronic rejection which is the most common 
cause of graft loss. Single and multicenter studies in adult and children have shown an 
association between acute rejection and subsequent development of chronic rejection  (Dart 
et al., 2010; Matas, 2000; Tejani & Sullivan, 2000). It is therefore expected that a reduction in 
the incidence of acute rejection - in our program the incidence of acute rejection in the 
period 2000-2010 has dropped to 7% - should result in the reduction of chronic rejection and 
thus in better long term graft survival. This is supported by a NAPRTCS study (Tejani et al., 
2002). Moreover some studies clearly indicate that a rejection free milieu can truly provide 
improved long term survival. Vats et al. in one of the largest single center study to date on 
long term graft outcome in pediatric renal transplant patients found freedom from acute 
rejection in the first year post-transplant to be the strongest independent predictor of 
improved graft survival (Vats et al., 2002). In an analysis of the UNOS data on 93934 adult 
patients, Hariharan et al. reported an increase in graft half-life from 11.9 years for patients 
with an episode of clinical acute rejection during the first year post-transplant to 27.1 years 
for those who did not have such an episode (Hariharan et al., 2000). Meier-Kriesche group, 
on the contrary, reported that the significant reduction in the acute rejection rates observed 
in the modern era has resulted in a marked improvement of the short term graft survival but 
in negligible progress in longer term survival as the attrition rate beyond the first year show 
little improvements (Lamb et al., 2011; Meier-Kriesche et al., 2004). 
We found kidney function at 1 year to be an independent predictor of long term graft 
survival indicating that preservation of renal function during the first year is important and 
that events occurring within the first year impacting on this function are of critical 
importance for long term survival. Several authors have reported that renal function after 
transplantation has a strong impact on long term graft survival. Hariharan et al. analysing 
factors influencing graft survival for 105742 adult renal transplants between 1988 and 1998 
reported one year creatinine and delta creatinine 6 months-1 year values to be the best 
predictors of long term survival and that the recent improvement in graft half-lives are 
related to conservation of renal function within the first year post-transplant (Hariharan et 
al., 2002). As it is the case in our study, when renal function within the first year and clinical 
acute rejection were included in their model for long term graft failure it was the creatinine 
at 1 year that was significant and not clinical acute rejection. Thus in the setting of acute 
rejection it is the preservation of renal function that is more important for graft survival. 
Data from a multicenter study pointed the 1 year estimated glomerular filtration rate to be 
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the most relevant predictor of long term graft function. The impact of DGF and acute 
rejection on the long term graft function appeared to be fully mediated by their influence on 
the 1 year GFR (Salvadori et al., 2006). Similar to us, three studies found allograft function at 
1 year to be a significant and independent predictor of graft outcome in children (Filler et 
al., 2002; Mitsnefes et al., 2003; Muscheites et al., 2009). Kidney function at one year might be 
thus a useful surrogate end point for renal transplant clinical trials in children.  
Anemia is a significant complication of renal failure being associated with numerous 
adverse outcomes, including compromised renal and cardiac function, cardiovascular 
disease, decreased exercise tolerance, cognitive impairment, poorer quality of life, increased 
risk for hospitalization and mortality (Koshy & Geary, 2008; Warady & Ho, 2003). Anemia is 
expected to resolve after transplantation. More and more data indicate on the contrary that 
anemia is a common phenomenon in pediatric kidney recipients with reported prevalence 
rates ranging from 25% to 80% depending on the definition of anemia used and the time 
post-transplantation (Al-Khoury et al., 2006; Mitsnefes et al., 2005; Yorgin et al., 2002). The 
prevalence of anemia at 1 year (defined as hemoglobin level <11 g/dl (Al-Khoury et al., 
2006; Mitsnefes et al., 2005)) was 30% among our transplanted children. The pathogenesis of 
post-transplant anemia is multifactorial and include iron deficiency, bone marrow 
suppression effects of immunosuppressive medications and other therapeutic agents, 
chronic inflammatory conditions caused by infections, frequent blood draws, and 
deteriorating renal function (Al-Uzri et al., 2003). In our multivariable analysis, hemoglobin 
level at 1 year post-transplant was a significant predictor of long term graft outcome, a 
higher level of hemoglobin being associated with a lower risk of graft failure. When 
hemoglobin was dichotomized at 11 g/dl, the HR for anemia in the multivariable model 
was 1.93 (p=0.024; 95% CI 1.09-3.42) while the HRs of the other covariates (table 5) remained 
in the same order of magnitude (data not shown). It was significant in the presence of 
“kidney function” indicating that anemia is just not merely a surrogate marker of a 
declining function of the allograft. Anemia is an independent risk factor for progression of 
renal failure in pre-dialysis adults (Kovesdy et al., 2006) and treating anemia slows down 
the decline of kidney function in these patients (Gouva et al., 2004). Our findings are in line 
with several studies in the adult population showing post-transplant anemia to be 
associated with increased risk for subsequent graft loss (Chhabra et al., 2008; Imoagene-
Oyedeji et al., 2006; Kamar & Rostaing, 2008; Molnar et al., 2007). In these studies, anemia 
was also associated with impaired patient survival and with a higher proportion of 
cardiovascular deaths. Whether this is also the case in children remains to be determined 
but a cross sectional study of pediatric kidney recipients pointing anemia to be predictive of 
left ventricular hypertrophy - an independent predictor of cardiovascular morbidity and 
mortality in adults - raises concern. Post-transplant anemia has also been reported to impact 
on the quality of life; anemic children presenting more physical discomfort (Riano-Galan et 
al., 2009). For all these reasons including our findings that anemia predicts poorer graft 
survival, anemia deserves to be recognized early after transplantation, properly investigated 
and corrected. 
The presence of marked proteinuria at 1 year was in our study population a strong and 
independent predictor of impaired graft outcome. This is in good agreement with several 
studies in adults showing increasing levels of proteinuria at 1 year post-transplant to be 
associated with increasing risk of graft failure (Amer et al., 2007; Fernandez-Fresnedo et al., 
2004; Roodnat et al., 2001). Persistent proteinuria is also associated in these studies with 
increased mortality. In our population, persistent proteinuria was attributed to biopsy 
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proven chronic allograft nephropathy, recurrence of primary kidney disease (FSGS and 
dense deposit disease) and de novo glomerulonephritis; this is in line with reports in adult 
kidney recipients (Barama, 2008). The underlying cause of proteinuria and not the 
proteinuria per se could thus be the factor contributing to transplant dysfunction and 
failure. However it is now recognized that proteinuria is not only a sensitive marker of renal 
disease but is directly damaging to the kidney by various mechanisms including direct 
mesangial toxicity, tubular overload, induction of a proinflammatory state and release of 
substances associated with the development of fibrogenesis and glomerulosclerosis (Baines 
& Brunskill, 2008). Recent reports indicate that even early (1-3 months post-transplant) very 
low (<0.5 g/24 h) and low grade (<1 g/24 h) proteinuria - often referred as ‘subclinical’ or 
‘negligible’ - is a potent predictor of graft loss in adult kidney recipients and that short term 
reduction in proteinuria is associated with improved long term graft survival (Halimi et al., 
2005; Sancho Calabuig et al., 2009). 
While ACE inhibitors have been shown to be effective and safe in proteinuric adult kidney 
recipients (Barama, 2008; Hiremath et al., 2007), there is a paucity of data in the pediatric 
transplant population. In one retrospective study, children treated with ACEI had slightly 
lower proteinuria than those who did not receive such treatment (Arbeiter et al., 2004). A 
recent uncontrolled small prospective study showed a reduction of proteinuria in nearly all 
children treated with ACEI (Seeman et al., 2010). 
Several factors such as donor source, donor age, recipient age and hypertension were in 
contrast with the literature not found significant in our study. 
Large registry and single centers studies show better graft survival for recipients of LRD as 
compared to recipient of DD kidney (Gjertson & Cecka, 2001; Magee et al., 2008; NAPRTCS, 
2010). Data from the NAPRTCS indicate that the 1 year graft survival obtained with 
deceased donors has reached that of the living donors. In our population, graft survival is 
also equivalent with both donor sources at 1 year and thereafter superior for LRD. However, 
this difference is not statistically significant, possibly because of the small number of LRD 
recipients. Another explanation is that we achieved good survival rates with the DD 
recipients, due to our strict policy of donor selection, good HLA matching and short 
ischemia times.  
There are a number of reports indicating poorer results with kidney from young donors, 
essentially due to an increase incidence of vascular thrombosis, primary non function and 
other technical causes (Cransberg et al., 2000; Postlethwaite et al., 2002; Seikaly et al., 2001). 
Earlier NAPRCTS reports of poor graft survival with young donors have led to a constant 
decrease of the use of these donors in pediatric recipients: donor younger than 10 years 
represented 38% of the DD for pediatric recipients in the 1988 cohort, 13% in the 2000 
cohort, 8% in the 2005 cohort and less than 5% in the 2009 cohort (NAPRTCS, 2010). We 
have obtained good results with young deceased donors with short and long term survival 
comparable to older donor (Van Damme-Lombaerts et al., 2001). Data indicate also that 
pediatric donor organs perform better than adult donor organs in pediatric patients 
(Nashan, 2004; Pape et al., 2004) and it seems thus justify that pediatric donors should 
preferentially be allocated to pediatric recipients. This might be stimulated by a very recent 
analysis of the NAPRTCS registry showing comparable 3-year graft survival and 
comparable kidney function in recipient of young donors (Moudgil et al., 2011).   
Young recipient age (<5 yr) has been traditionally associated with poorer short term graft 
survival due to a high incidence of vascular thrombosis, technical complications and acute 
rejection (Cransberg et al., 2000; Gagnadoux et al., 1993; Kari et al., 1999; Postlethwaite et al., 
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2002). However, there are a few single center reports, including ours, indicating that 
excellent renal transplantation results can be obtained in this high risk group of patients 
with careful and meticulous surgical techniques, vigilant management of fluids 
administration, use of low molecular weight heparin in the early postoperative period and 
close monitoring of immunosuppression with early diagnosis and treatment of rejection 
(Gagnadoux et al., 1993; Ojogho et al., 2002; Vats et al., 2002). Furthermore, past the first 
post-transplant year, graft survival in these youngest children has been reported to be 
excellent: as good or even superior to older children and adults (Gjertson & Cecka, 2001; 
Ojogho et al., 2002; Vats et al., 2002). 
In our study hypertension was not a significant predictor of graft failure. This may be due 
to the fact that we relied on the use of antihypertensive medications and their numbers as 
surrogates for defining hypertension and its severity. Studies using actual blood pressure 
measurements found early post-transplant hypertension to be a significant and independent 
predictor of early allograft function and long term graft outcome in pediatric renal 
transplant recipients (Mitsnefes et al., 2003; Mitsnefes et al., 2001). 
5. Conclusion 
Despite its limitation due to the small number of patients, our study shows that several 
factors influence the outcome of renal allograft in our pediatric population. The introduction 
of CsA had a very significant impact in improving graft survival. A good HLA match 
remains important and matching for HLA-A locus in children should not be neglected. 
Early recognition, investigation and treatment of post-transplant anemia and proteinuria 
may play an important role in ultimately improving outcomes. 
Prevention and adequate management of DGF, prevention and effective treatment of acute 
rejection episodes, therapeutic monitoring of calcineurin inhibitors to limit their 
nephrotoxicity, prevention of other injuries to the allograft by factors such as severe 
infection, hypertension, obstruction should contribute to the preservation of the renal 
function during the first year and lead to improved long term outcome. 
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